Dr. Primrose on Adjuvant Capecitabine For Biliary Tract Cancer
0 Views
administrator
07/09/23
John Primrose, MD, ChB, FRCS, professor of medicine/surgery, University of Southampton, United Kingdom, discusses the impact of adjuvant capecitabine in patients with biliary tract cancer.
Show more
Facebook Comments
No comments found